Literature DB >> 9181841

[EOG in adult vitelliform macular degeneration, butterfly-shaped pattern dystrophy and Best disease].

M Theischen1, H Schilling, U H Steinhorst.   

Abstract

OBJECTIVES: We evaluated the EOG in the various stages of foveomacular dystrophy (also called adult-onset vitelliform macular dystrophy) and compared these findings to those in Best's disease and butterfly-shaped dystrophy. PATIENTS AND METHODS: The records of 49 patients (98 eyes) in whom foveomacular dystrophy had been diagnosed by ophthalmoscopy or by fundus photographs and fluorescein angiography were retrospectively reviewed. Fifty-seven eyes were followed up (range 1.1-20 years, mean 10.4 years). EOG was elicited according to the method of Rohde and Täumer. The results were compared to those in Best's disease and butterfly-shaped dystrophy.
RESULTS: In foveomacular dystrophy all mean EOG values were within normal ranges. There was no difference between the various stages of the disease. In Best's disease only the dark-adapted steady-state potential was in the normal range. The amplitude and the implicit time of the light peak were significantly different from those in patients with foveomacular dystrophy (P < 0.05 ANOVA). In butterfly-shaped dystrophy all the EOG parameters were normal. The ratio of the light peak to steady-state potential was significantly lower in foveomacular dystrophy than in butterfly-shaped dystrophy.
CONCLUSION: In foveomacular dystrophy the mean values of the EOG were normal. Despite the morphological similarity we found more pronounced electrophysiological differences from Best's disease than from butterfly-shaped dystrophy.

Entities:  

Mesh:

Year:  1997        PMID: 9181841     DOI: 10.1007/s003470050107

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  5 in total

1.  Detection of retinal dysfunction in vitelliform macular dystrophy using the multifocal ERG (MF-ERG).

Authors:  Anja M Palmowski; Reiner Allgayer; Bernhild Heinemann-Vernaleken; Volker Scherer; Klaus W Ruprecht
Journal:  Doc Ophthalmol       Date:  2003-03       Impact factor: 2.379

Review 2.  Molecular genetics of macular degeneration.

Authors:  M A Musarella
Journal:  Doc Ophthalmol       Date:  2001-05       Impact factor: 2.379

Review 3.  Genotype-phenotype correlations and differential diagnosis in autosomal dominant macular disease.

Authors:  A Iannaccone
Journal:  Doc Ophthalmol       Date:  2001-05       Impact factor: 2.379

4.  Electronegative electroretinogram associated with topiramate toxicity and vitelliform maculopathy.

Authors:  Irena Tsui; Daniel Casper; Chai Lin Chou; Stephen H Tsang
Journal:  Doc Ophthalmol       Date:  2007-10-03       Impact factor: 2.379

5.  [Clinical diagnostic prerequisites for adult vitelliform macular dystrophy].

Authors:  A B Renner; H Tillack; H Kraus; U Kellner; M H Foerster
Journal:  Ophthalmologe       Date:  2004-09       Impact factor: 1.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.